Abstract
In this study, we investigated the reverse transcriptase subunit of telomerase in the dimorphic fungus Ustilago maydis. This protein (Trt1) contains 1371 amino acids and all of the characteristic TERT motifs. Mutants created by disrupting trt1 had senescent traits, such as delayed growth, low replicative potential, and reduced survival, that were reminiscent of the traits observed in est2 budding yeast mutants. Telomerase activity was observed in wild-type fungus sporidia but not those of the disruption mutant. The introduction of a self-replicating plasmid expressing Trt1 into the mutant strain restored growth proficiency and replicative potential. Analyses of trt1 crosses in planta suggested that Trt1 is necessary for teliospore formation in homozygous disrupted diploids and that telomerase is haploinsufficient in heterozygous diploids. Additionally, terminal restriction fragment analysis in the progeny hinted at alternative survival mechanisms similar to those of budding yeast.
Introduction
Telomerase is a specialized ribonucleic protein complex that synthesizes the repetitive G-rich-DNA motifs constituting telomeres in most eukaryotic cells. The central enzyme components are the telomerase reverse transcriptase (TERT) protein subunit, which is a specialized reverse transcriptase, and the RNA template for telomere DNA synthesis (TR); both of these components are tightly regulated in normal cells [1], [2]. This enzyme plays an important role in telomere lengthening and has been intimately associated with cellular proliferation not only through its telomere-lengthening activity but also through its recently discovered non-telomeric roles [3], [4]. The reverse transcriptase subunit and RNA template are required for telomere synthesis, but in vivo, the TERT subunit is the limiting factor for restored telomerase activity in telomerase-downregulated cells. Therefore, most studies on telomerase regulation have focused on the TERT subunit gene [5], [6].
TERT subunit expression and activity have been detected in unicellular eukaryotes and metazoans. TERT can be regulated by diverse mechanisms, including both transcriptional regulation and posttranscriptional alternative mRNA splicing, multimerization, phosphorylation of the telomerase catalytic subunit and ncRNA interactions [7]–[9]. TERT gene expression and telomerase activity have been detected in immortal cells, such as cancer cell lineages and in germinal and pluripotent cells [10]–[12]; however, in most somatic cells, the TERT gene is gradually downregulated as cellular development progresses in the metazoan life cycle, and telomerase activity eventually becomes undetectable [11], [13]. Because conventional polymerases fail to replicate chromosome ends, telomerase downregulation results in telomere shortening in each replication round until a critical length is reached [14]. At this point, in telomerase-deficient cells, cellular proliferation ceases, senescence begins, and self-renewal capability decreases.
In Saccharomyces cerevisiae, the EST2 gene encodes the reverse transcriptase subunit of telomerase, and its expression is tightly regulated throughout the yeast cell cycle. When EST2 is mutated, yeast show a senescent phenotype, and their life span is reduced, as evidenced by an increase in cell death [15]. Eventually, survivors do appear through homologous recombination pathways, which cause rearrangements in telomeric and subtelomeric sequences that ensure the maintenance of telomere function [16]. Based on their telomere pattern, yeast survivors are classified into two types: Type I survivors, which exhibit tandem amplification of the Y' element followed by small tracts of telomeric C1–3A/TG1–3 DNA; and Type II survivors, which show very long and heterogeneous tracts of C1–3A/TG1–3 DNA at chromosome termini. The growth and maintenance of the two types of telomere structures have specific genetic requirements, involving more than a dozen genes [17]. In yeast cells, the programmed downregulation of EST2 does not occur, and natural telomere attrition through successive rounds of DNA replication does not appear to be the main cause of replicative senescence. In this organism, replicative senescence has primarily been associated with the control of genetic pathways involving rDNA metabolism, mitochondrial dysfunction, and proteasome function [18]. The participation of telomere dysfunction by means other than programmed EST2 downregulation in natural replicative senescence is currently under investigation. Other lower eukaryotes that undergo developmental transitions in their life cycle could be useful model systems to analyze the evolutionary pathways used to promote telomere maintenance and control by comparing their features with those of vertebrates or yeast-like organisms.
Ustilago maydis, a smut fungus that triggers the formation of tumors in maize, is a well-established model organism [19]–[22]. As a biotrophic pathogen, this fungus is an obligate parasite that depends on its host to complete its life cycle. Fungal infection is initiated with the recognition and mating of two compatible yeast-like cells, known as sporidia, on any of the aerial parts of the maize plant [23], [24]. Once plasmogamy occurs, the fungus enters into the plant tissue; tumor formation is then governed by a heterodimeric transcriptional regulator that triggers a dimorphic transition and pathogenic development and regulates mycelial growth and teliospore formation [25]–[27]. Regulatory cascades are initiated for a plethora of genes encoding transcriptional regulators, protein effectors, and virulence factors that subdue plants' defense responses; these processes result in tumor gall development, teliospore formation, and life cycle completion [28], [29]. In U. maydis, the TTAGGG motif composes the chromosomal end repeats [30]. Analysis of the terminal restriction fragment (TRF) by Southern blotting has indicated that U. maydis telomeres are maintained by telomerase [31]. In this study on telomere metabolism in this fungus, we report the identification and functional characterization of the U. maydis telomerase reverse transcriptase gene trt1.
Results
Identification and disruption of the Trt1 gene in U. maydis
Bioinformatics analysis of the annotated U. maydis genome (http://mips.helmholtz-muenchen.de/genre/proj/ustilago/) revealed that telomerase reverse transcriptase is encoded by a single, uninterrupted open reading frame (ORF). This ORF is predicted to yield a 1371-residue protein that contains all of the conserved domains found in the telomerase catalytic subunits of humans, plants, and fungi. These domains include the seven conserved RT motifs (1, 2, A, B′, C, D, and E) in the reverse transcriptase domain (shown in green, Fig. 1A and 1B) and the conserved motifs CP, QFP, and T from the RNA-binding domain, whose function is required for RNA subunit- binding (shown in red, Fig. 1A and 1B). In addition, the N-terminal region has the potential to house a GQ block (shown in blue, Fig. 1A and 1B).
To confirm that trt1 encodes the Trt1p subunit of U. maydis telomerase, we deleted this gene from the haploid 521 strain using standard one-step gene disruption methodology (Fig. 2A). Gene disruption was scrutinized by multiplex PCR using primers designed to detect the absence of the trt1 coding region and its replacement with the hygromycin resistance gene, which was used as a selection marker (Fig. 2B, upper gel, lanes 3 and 4). Disruption was confirmed by the PCR amplification of a 1,942 bp fragment spanning the hygromycin resistance gene and regions outside the disruption cassette (Fig. 2B, lower gel, lanes 3 and 4). Ectopic recombination events were identified by a double-band electrophoretic pattern that corresponded to wild type and disruption cassette sequences (Fig. 2B, upper gel, lanes 5 and 6). The absence of trt1 disruption was indicated by a lack of DNA bands in the DNA amplification pattern (Fig. 2B, lower gel, lanes 5 and 6). Subsequently, a representative mutant clone, trt1-1, was streaked after 12, 60, 156, and 180 generations in subculture passages (Fig. 2C). Poor growth and low replicative potential were observed, supporting the notion that replicative senescence occurs in the U. maydis trt1-1 mutant.
Telomere length analysis in trt1-disrupted mutants
To analyze the telomere length, trt1-1 mutant cell samples growing in continuous culture were acquired periodically (Fig. 3, lanes 1 to 8), and the DNA was isolated, quantified, and examined by Southern blotting. The 36-generation series initiated after approximately 76 doubling periods, when considerable telomere shortening had occurred compared with the wild-type strain (Fig. 3A, compare lanes labeled control ‘521’ and 1). Progressive telomere shortening continued as the replication rounds increased, and the hybridization signals began to fade at generation 256, when the sequences surveyed with the telomere probe were too short to yield a strong TRF signal (Fig. 3A, lanes 3 to 6). These results are consistent with previously reported telomere lengths [32]. The survivors, comprising a small group of telomerase-negative cells that employed homologous recombination-based pathways as an alternative method for telomere maintenance and proliferated past senescence, were obtained after 256 generations. Slight rearrangements in the hybridization pattern, such as changes in the size of signal bands (Fig. 3A, arrows on the left), their intensity, and the appearance of light smears along the last two lanes, were observed with the telomere probe at 292 and 328 generations (Fig. 3A, lanes 7 and 8).
To search for subtelomeric region rearrangements, we reprobed using the UT4-a probe from the subtelomeric UTASa gene [32]. Minor changes in the hybridization pattern that primarily correlated with a subtelomeric UTASa-like sequence shortening were observed (Fig. 3B, lanes 1 to 5); however, at later times in the survivor TRF pattern, two signal bands appeared at a high-molecular-weight resolution zone (Fig. 3B, lanes 7 and 8, upper arrows) as did smearing of the hybridization signals derived from subtelomeric sequences in survivor clones, which are detailed below.
Telomerase activity in U. maydis
The telomerase activity in extracts from wild type sporidia was measured with TRAP-ELISA (telomeric repeat amplification protocol-enzyme-linked immunosorbent assay), a widely used assay developed to measure telomerase activity in mammalian cells. This assay is based on a one-step PCR procedure coupled with the chromogenic detection of telomeric repeat products. Extracts prepared from U. maydis 521 sporidial cells contained telomerase with a specific activity (activity per equivalent mass of protein) of approximately half the level found in control human HEK293 cells (Fig. 4, first and fourth bars; Table 1, first and second rows). Sample extracts from the HEK293 cell line and the U. maydis 521 strain heated at 85°C (Fig. 4, second and fifth bars) or treated with RNase (Fig. 4, third and sixth bars) had no activity compared with their corresponding non-treated positive controls (P<0.05). To determine whether telomere shortening in the trt1-1 clone correlated with a lack of telomerase activity, further TRAP-ELISAs were performed (Fig. 4, seventh, ninth and tenth bars; Table 1, third row). An additional independent trt1 disrupted mutant (the trt1-2 clone) was also tested (Fig. 4, eighth bar; Table 1, fourth row). No significant differences (P>0.05) in activity were observed between the trt1-disrupted, heated, RNase-treated and gall cell extracts (Fig. 4, twelfth bar), indicating that these samples contained no detectable telomerase activity, as no activity was detected in the maize leaves (Fig. 4, eleventh bar; Table 1, fifth and sixth rows). Pairwise comparisons of the statistical means between the telomerase-positive and telomerase-negative samples using Mann-Whitney analysis revealed significant differences between the two groups of data (P<0.01). With this result accompanying the previous findings, we conclude that U. maydis synthesizes its telomeres with trt1 telomerase activity.
Table 1. Determination of telomerase activity in U. maydis strains.
Cell type | Cell extract treatment* | ||
None | Heated | RNase | |
HEK293 | 1.599 | 0.145 | 0.219 |
521 strain | 0.870 | 0.180 | 0.307 |
trt1-1 | 0.261 | 0.206 | 0.118 |
trt1-2 | 0.249 | N.D. | N.D. |
Plant | 0.081 | N.D. | N.D. |
Tumor (520×521) | 0.182 | N.D. | N.D. |
The average absorbance values yielded by the telomerase activity in cell extracts are numerically expressed and shown in the chart. The absorbance for each sample was calculated according to the manufacturer's instructions and is shown. Heat- (85°C) and RNase-treated samples were used as negative controls. Telomerase activity was measured under the same conditions in the positive controls and tested samples. Telomerase activity was measured only in the mutant trt1-1; telomerase-negative samples (either from mutants, tumors, or plants) were not treated with heat or RNase, and their activity was not determined (N.D.). All of the experiments were performed at least three times.
* Media of at least three repetitions.
The Trt1 activity is necessary for U. maydis teliospore formation
In planta crosses of wild type and telomerase-negative mutants were conducted to determine the effects of trt1 disruption on the ability of U. maydis to complete its life cycle. Heterozygous or homozygous crosses for trt− were performed. In the heterozygous trt− crosses, the time when disease symptoms appeared in the infected plants was indistinguishable from the time of the wild-type control crosses (Fig. 5A and D; Table 2, ‘Symptoms’), but these crosses had lower teliospore production in the galls (Fig. 5B and E). In the heterozygous crosses, the number of plants with symptoms, immature tumors, or mature tumors was large (Table 2, see rows ‘Teliospore content in mature galls’, ‘Immature galls’ and ‘Mature galls’). Tumors were pale (Fig. 5G and H) or anthocyanin-rich (Fig. 5I and J). Homozygous crosses for trt1-1 (a1b1) were attained with trt1-53 (a2b2), a strain derived from the heterozygous cross trt1-1 ×520 (Table 3). In the homozygous trt− crosses, the disease symptoms were less frequent (Fig. 5C and F). Tumors arose from homozygous trt1-disrupted dikaryons, but the tumors appearing in the leaves healed (Table 2, ‘Tumor gall healing’). In galls that developed on the stalk, mature teliospores were absent (Fig. 5C and D right; Table 2, Teliospore content). Thus, we conclude that the trt1 gene is required for teliospore formation.
Table 2. Time course of maize infection with mutant and wild-type strains of U. maydis.
521×520a | trt1-1 X 520b | trt1-1 X trt1-53c | ||||
Infection characteristics | Day | % | Day | % | Day | % |
Symptoms appearing | 5±2 | 57±8 | 5±2 | 88±12 | 5±2 | 25±1 |
Immature galls | 11±1 | 57±7 | 12±2 | 72±12 | 12±8 | 19±6 |
Mature gall | 15±2 | 60±6 | 21±2 | 76±7 | 20 | none |
Teliospore content in mature galls | 15 | +++/++++ | 26 | +/+++ variable | 25 | none |
Tumor gall healing | 15 | none | 30 | none | 25 | All of leaves |
New tumor appearance | 15 | none | 30 | ∼7 | 25 | ∼9 |
The wild-type 520 and 521 strains and their compatible derivatives trt1-1 and trt1-53 were used to perform in planta mating to determine the effects of the mutant trt1 gene on cell cycle completion. The infectious process is listed on the left along with the disease signs and symptoms and lesion characteristics. The names of the compatible strains are shown above each column pair, and the mating genotype is displayed below. Column pairs were used for each compatible mating to show the percentages of plants assayed on the day of sign or symptom appearance.
Wild-type X Wild-type.
Mutant X Wild-type.
Mutant X Mutant.
Table 3. U. maydis strains used.
Strain | Genotype | Source |
521 | a1b1 | W. K. Holloman |
trt1-1 | a1b1, trt1::hph | This work |
trt1-2 | a1b1, trt1::hph | This work |
520 | a2b2, nar1-1, met1-2 | W.K. Holloman |
520trt1-1 | a2b2, nar1-1, met1-2* | This work |
trt1-53 | a2b2, trt1::hph | This work, F1 from trt1-1 X 520 |
W204 | a1, b1, trt1::hph | This work, F1 from trt1-1 X 520 |
T2 | a1, b1, trt1::hph, pTrt1 | This work, W204 transformed with pTrt1 |
521pNEB | a1b1, pNEBUC GE77+ | This work |
*Partially characterized.
Insights into the telotype of the post-meiotic progeny
To investigate telomere length in the meiotic products of a heterozygous trt1-1 ×520 cross, we germinated the resulting teliospores on solid medium in the presence or absence of hygromycin. These progeny were designated as F1. Total DNA was extracted from selected F1 progeny, and PCR was used to search for the inherited trt1 allele (Fig. 6A and B, lower panels). Five telomerase-negative strains derived from the heterozygous trt1-1 cross, referred to as W202, W203, W204, W208, and W2010, and five telomerase-positive strains from the same cross, named W207, W212, W218, W224 and W225, were selected for PCR analysis (Fig. 6A, lanes 1 to 5 and B, see legends in upper panels). We also performed heterozygous crosses of wild type and trt1-disrupted clones with the 520trt1-1 strain. This strain is an a2b2, telomerase-positive transformant clone with limited proliferative potential, affected telomere length maintenance and a TRF pattern similar to that of trt1-2, (Table 3; Fig. 6A, lane 20). Five telomerase-negative strains, designated here as delta (Δ), and five telomerase positive strains, referred to as W02+1 to W02+5, were selected and analyzed (Fig. 6, lanes 6 to 10 and lanes 11 to 15, respectively, see upper panel). The analyzed telomerase-negative strains produced a 1,286-bp amplified fragment that spanned parts of the trt1 and hph genes, whereas the telomerase-positive strains produced a 904-bp amplified fragment from the trt1 gene (EE; Fig. 6A to C, lower panels).
The terminal restriction fragment length was then analyzed in the F1 progeny mentioned above, the wild-type 521 and 520 strains, the disrupted derivatives trt1-1 and trt1-2, and the 520trt1-1 strain. This experiment used the UT1-a probe, a Sau3AI terminal restriction fragment that spans 240 bp from the telomeric repeated TTAGGG motif and 360 bp from a highly conserved sequence located adjacent to telomeric repeats and interspersed with telomere associated sequences (Fig. 6D) [30]. The latter element has also been previously reported to comprise TR-p + TR-d sequences, which together form a 329-bp Sau3AI-HincII DNA fragment riven by the PstI recognition and excision site [27]. Two principal hybridization patterns were obtained from the progeny TRFs. One pattern exhibited abundant amplification of the telomeric sequences and its associated sequences, showing intense hybridization signals mainly at resolution zones around 0.3, 0.7, and 1.7 kb (Fig. 6A, lanes 1 to 5, Δ14, Δ25, and trt1-1; Fig. 6B, W207, W212, W218, W224 and W225). The other pattern was composed of a mixture of wild-type and mutant hybridization signals from the chromosomal terminal sequences, which were long, heterogeneous, and variable in intensity (Fig. 6A, Δ5, Δ21, Δ50, and W02+1 to W02+5, and 520trt1-1). The TRF patterns were similar between the trt+ and trt- disrupted strain progenies of the trt1-1 ×521 cross (compare Fig. 6A, W202, W203, W204, W208, and W210 with; Fig. 6B, W207, W212, W218, W224 and W225), as were similar those of trt+ and trt- progenies from heterozygous 520trt1-1 crosses (In Fig. 6A, compare W02+1 to W02+5 with Δ5, Δ21 and Δ50). The preservation of the hybridization pattern from the parental survivor across several generations in the telomerase-positive progeny from heterozygous crosses suggests the haploinsufficiency of the TERT component, which will be discussed later. In all strains, the PCR amplification patterns of the wild-type and trt1-disrupted alleles are shown at the bottom of Figure 6.
Extrachromosomal complementation of Trt1 mutants
The telomerase-negative survivor W204 strain, which was derived from the 520× trt1-1 cross, and the wild-type 521 strain were transformed with self-replicating plasmids expressing Trt1 (pTrt1) or a vector alone and were selected with carboxin resistance. The acquisition of pTrt1 into W204 transformants (T1 to T5) was confirmed with drop-plate assays (Fig. S1A) and with the genetic re-transformation of E. coli XL1-Blue MRF' with total DNA extracted from clones (data not shown). PCR amplification of DNA sequences from pTrt1 indicated that the plasmid was present in all five clones (Fig. S1B). Transcriptional expression of chimeric trt1 was examined in three transformants (T1 to T3) by RT-PCR as described in Material and Methods section. The detection of trt1 transcripts in the transformant clones suggested a functional complementation of the trt1-disrupted W204 mutant that depended on the exogenous chimeric gene (Fig. S1C). Regaining telomerase activity in the three transformant clones confirmed our assertion (Fig. S1D); however, as shown in the Table S1, telomerase activity varied between the T1 to T3 tested strains after complementation (Table S1, rows 2, 5, 6 and 7). Trt1 expression restored the replicative potential and growth rate to almost normal levels in the W204 derived strain T1 and decreased the growth rate in the 521 strain (Table 4). A slight decrease in intensity in the telomere signals from the genomic hybridization patterns of the pTrt1 transformants was observed after 200 doublings compared with the untransformed W204 strain (Fig. 7A, lanes 5 to 10). This change was accompanied by minor telomeric and subtelomeric rearrangements in the banding patterns (Fig. 7B, lanes 5 to 10), but no modifications were observed after 400 generations in 521 transformants with the pTrt1 or vector alone (data not shown). Thus, we assume that the deficient W204 strain was complemented with pTrt1.
Table 4. Extrachromosomal trt1 complementation and growth rate restoration.
Strain | Transformant condition | Growth rates in min (hours) |
521 | Non-transformed | 80 (1∶20 h) |
Transformed with pTrt1 | 285 (4∶45 h) | |
Transformed with pNEBUC-GE77+ | 216 (3∶36 h) | |
W204 | Non-transformed | 815 (13∶35 h) |
Transformed with pTrt1 (T1) | 122 (2∶02 h) | |
Transformed with pNEBUC-GE77+ | N.D. |
After restoring the replicative potential by trt1 reintroduction, the growth rate was analyzed in the transformants with the same method used for the non-transformed controls. The strains analyzed are shown on the left, and the plasmids used to transform these strains are indicated at the top. In parentheses, minutes were changed to hours.
Time course of chromosome end degradation in U. maydis
As the sequences on or near the chromosome termini shorten in telomerase-deficient cells, a time course assay of Bal31 digestion was performed. This assay compared the pattern of telomere loss by telomerase deficiency to the pattern of telomere loss by TRF exonuclease treatment in the 521 as well as in the trt1-1 survivor, derivative W204 and complemented T2 clones. For the 521 strain, long smears corresponding to the (TTAGGG)n hybridization pattern and extending from 0.3 to 3 kb were accompanied by six discrete bands in the resolution zone that ranged from 2 to 12 kb after UT4-a-probe hybridization in the autoradiogram at time 0 (Fig. 3B and S2A). The telomere smears gradually shortened (Fig. S2A, 30 min) or faded (Fig. S2A, 60 and 90 min), whereas the UT4-a hybridization signals remained insensitive to Bal31 exonuclease treatment during the 90-min treatment period (Fig S2A, 0 to 90 min), with exception of a 2.5-kb band. The requirement of a longer digestion time to erode the UT4-a bands reflects the inner localization of these sequences within the chromosomes. After membrane stripping and rehybridization to ribosomal rDNA sequences, the hybridization signals did not change on the blots because the internally located genes had no sensitivity to Bal31 (Fig. S2B, 0 and 90 min).
In the telomerase-negative survivor trt1-1, W204 and T2 transformant, strong hybridization signals for telomeric DNA were distributed from 0.3 to 12 kb (Fig. S2C, S2D and S2E, respectively). Hybridization bands of approximately 0.6 kb in the trt1-disrupted mutant trt1-1 (Fig. S2C, 0 min) and 4 kb from complemented T2 strain (Fig. S2E, 0 min) were partially sensitive to Bal31 action at short incubation times (Fig. S2C, 10 min, arrow and Fig. S2E, 20 and 30 min, arrow), whereas the remaining hybridization signal was insensitive to exonuclease digestion at longer incubation times (90 min, data not shown).
Discussion
Here, we described the results of the disruption of the locus um11198 (MUMBD) in the U. maydis genome, which harbors the putative telomerase reverse transcriptase (trt1) gene. Alignment analysis indicated that it encodes a protein with all of the characteristic TERT domains (TEN, TRBD, RT, and CTE) in the same order and distances reported for other TERTs [33], [34].
After identifying telomerase activity in cell extracts of U. maydis, the trt1 gene was disrupted to confirm the induction of telomere erosion by a lack of telomere maintenance; the replicative senescence and loss of telomere repeats found in the mutant trt1-1 clone agreed with the previously reported absence of telomerase activity [35]. The appearance of slight smears in the DNA hybridization pattern of trt1-1 with the UT4-a subtelomeric probe suggested the presence of chromosome termini alterations of the mutant after 292 replication rounds. Similar changes have been reported to occur in telomerase-negative yeasts through recombinational pathways [35]. The development of telomerase-negative survivors in the trt1-1 mutant was confirmed after several subsequent passages.
No telomerase activity was found in the trt1-1 and trt1-2 mutants compared with the 521 strain or a human positive control. The absence of telomerase activity, the presence of telomere shortening, and the senescent phenotype coupled with slow growth and poor replicative potential of the trt1-1 clone support our assertion that trt1 is the reverse transcriptase catalytic subunit of the U. maydis telomerase.
In our TRF analysis, long heterogeneous tracts of telomeric sequences were observed in the trt1-2 mutant and in most progeny derived from heterozygous crosses of 520trt1-1 with 521 or the trt1-disrupted mutant. These TRF analyses resemble those characterized in the Type II survivor pattern of the S. cerevisiae est2 mutants [36]. However, the excessively amplified tracts of telomere-associated sequences linked to short segments of telomeric sequence that occurred in trt1-1 and trt1-53 match the Type I survivor pattern [36]. Although it is tempting to propose that trt1-2 progeny are similar to Type II S. cerevisiae est2 mutant survivors because of the excessive telomeric repeat sequence lengthening [35], it is more difficult to match trt1-1 and its progeny with the Type I survivor pattern because the length and identity of the amplified TAS by homologous recombination requires further characterization [35].
U. maydis and yeast survivors share similar characteristics: (a) the telomere structure and organization of mutant survivors prevail in the postmeiotic progeny from heterozygous diploids, as previously described [37], and (b) the inherited telomeric structure is preserved in haploid progeny for many generations, in trt+ or trt-, regardless of the inheritance of the functional trt1 allele in haploid cells, which occurs in yeast and mice [16], [38]. These similarities were unanticipated because of the distant relationship between these two fungal species.
Gall development from homozygous crosses of trt− mutants in planta suggests that the mechanisms for pathogenic development remained intact in these organisms. However, the lack of teliospore formation in these tumors indicates that Trt1 is indispensable for fungal life-cycle completion. This condition resembles the critical role of telomerase activity in the production and fertility of germinal cells in mammalian males and in the proliferation of human stem cells [10], [39], [40]. The delay in gall development may result from low mutant cell viability, the production of lower quantities of virulence factors, or a plant-cell/mutant growth ratio that influences the plant infection schedule, as the growth rate of the plant host is known to influence the pathogenic potential of U. maydis [41]. The roles of Trt1 in mycelium differentiation should be explored to explain the defective fungal differentiation process in the telomerase-negative mutants.
Insufficient telomerase activity was also found to affect telomere maintenance in the trt−/trt+ U. maydis heterozygotes. The lack of telomere pattern restoration observed in the telomerase-positive progeny after passaging through meiosis suggests Trt1 haploinsufficiency (Fig. 6B), which has been reported for humans, mice, and yeasts that are heterozygous for TERT or TR subunit null mutations [38], [42], [43]. Trt1 haploinsufficiency may also be responsible for the teliospore-lacking tumors produced by the trt−/trt+ heterozygous crosses.
Introduction of the plasmid pTrt1 but not pNEBUC-GE77+ into the W204 strain yielded transformants, reinforcing our affirmation of an effective complementation of W204 with the exogenous copy of trt1 in pTrt1. The decrease in intensity of the hybridization signal emitted by similar quantities of DNA from both the complemented strains and the telomerase-positive progeny suggested that a progressive reduction of TAS copies occurred after 200 doubling periods, resulting in a gradual reversion to the wild-type telomeric pattern. However, the replicative potential and growth rate were not fully recovered in the transformants. In contrast, a complete restoration of the growth rates and replicative potential occurs after the reintroduction of EST2 to telomerase-null yeast mutants [44]. The lack of complete restoration observed in U. maydis may be a consequence of limitations in trt1 expression.
Our analysis of the telomere structure also provided insight into the telomere maintenance that occurs at chromosome ends. A time course of Bal31 digestion of the telomeric DNA from the 521 strain demonstrated not only that (TTAGGG)n and UT4-a sequences are located mainly on the chromosome ends but also that the 521 strain and trt1-1 share similar patterns of telomere attrition post-Bal31 digestion and after several passages in cell culture. The telomeric and subtelomeric DNA sequences of the W204 strain were more resistant to Bal31 digestion than those of its pTrt1 transformant derivative T2. The exogenous reintroduction of trt1 seemed to attenuate DNA resistance to exonuclease action. Thus, we hypothesize that exogenous Trt1 contributes to the prevention of additional telomere enlargement via recombinational pathways; however, further studies should be conducted before comparing these findings with other models. Moreover, the survival mechanisms of the telomerase-negative U. maydis strains appear to rely on recombinational events, which also deserve further study and were recently proposed for telomerase-positive strains [45].
Finally, we assume that the U. maydis telomerase reverse transcriptase gene has been structurally and functionally characterized at the complementation level, but further analysis regarding telomerase function in this lower eukaryote remains to be performed.
Materials and Methods
Plasmids, strains, and mating assays
E. coli XL1-Blue MRF' (Stratagene, La Jolla, CA, USA) were used as the receptor strain for plasmid construction. Unless otherwise specified, this strain was grown overnight (O/N) at 37°C with aeration in LB medium supplemented with 100 µg/ml ampicillin when necessary. The plasmids used were as follows: pBluescript KS- (Stratagene), pTrcHis 2A (Invitrogen, Carlsbad, CA, USA), pCM1007, which contains a trt1 disruption cassette and was kindly provided by Dr. W.K. Holloman (Weill Cornell Medical College, NY, USA); pUBLEX1 [46], which was supplied by Dr. Fidel Guevara Lara (formerly at CINVESTAV-IPN, Campus Guanajuato, Mexico); a pA plasmid clone containing a 7.3-kb EcoRI subfragment of human rRNA genes spanning the 5.8 plus 28S subunits, which was provided by J.E. Sylvester (University of Pennsylvania, PA USA); and pNEBUC GE77+, which is related to the pMF1-c plasmid and was provided by Dr. Michael Feldbrügge (Institute of Microbiology, Heinrich-Heine-Universität, Düsseldorf, Germany) [47].
Table 3 lists the U. maydis strains used. The U. maydis sexually compatible strains 520 (a2, b2, nar1-1, and met1-2) and 521 (a1 and b1) were the parental strains. All of the fungal strains were grown at 30°C in the following culture media: potato dextrose broth (PDB) or agar (PDA) from Difco (Becton Dickinson and Company, Sparks MD, USA); YEPS medium [1% yeast extract (Difco), 2% Bacto peptone (Difco), and 2% sucrose]; complete (CM) or minimal (MM) medium as previously described [48]; and mating medium containing 1% active charcoal [23]. Media were supplemented with either 150 or 200 µg/ml hygromycin (Invitrogen) as specified or with 1 µg/ml carboxin (Cbx; BioWorld, Dublin, OH, USA) when necessary. Fuz+ mating assays were performed on charcoal nutrient medium as previously described [23], [48].
Plant infection with U. maydis
Plant infection was achieved as previously described [48], [49]. U. maydis cells were grown in YEPS medium (1% yeast extract, 1% peptone, and 2% sucrose) at 28°C for 14 h. Mixtures of compatible strains were prepared, and 100 µl of these cell suspensions was injected into five-day-old maize seedlings (MCS-02) [49]. The tumor tissues were harvested at 15–30 days post-inoculation (dpi), processed or frozen, and stored at −70°C until nucleic acid extraction. To recover the progeny, mature teliospores were germinated on solid medium supplemented with hygromycin (150 µg/ml) when necessary [48]. After germination, the sporidia were re-streaked in duplicate on medium supplemented with and without hygromycin (150 µg/ml). Progeny strains were grown on MC supplemented with hygromycin when needed and stored in a solution 15% (v/v) glycerol at −70°C until analysis.
Nucleic acid manipulation
DNA was prepared from 20 ml of U. maydis culture grown O/N. Protoplasts of the harvested cells were prepared as described in [50] using 20 mg/ml of Lysing Enzymes from Trichoderma harzianum (L1412; Sigma-Aldrich Co, St. Louis, MO, USA). The protoplasts were collected, and 1 ml of extraction buffer (200 mM Tris-HCl, pH 8.5; 250 mM NaCl; 25 mM EDTA; and 0.5% SDS) was added to the cell pellet and mixed to homogeneity. Phenol-chloroform extraction was conducted twice with 15-min centrifugation intervals to purify the DNA. The aqueous phase was washed once with chloroform and precipitated with 0.6 v/v isopropanol. The DNA was recovered and suspended in 100 µl of sterile distilled water and re-extracted with phenol. The DNA was then suspended in sterile distilled water.
For Southern blot assays, the DNA was quantified prior to and after restriction enzyme digestion with a VersaFluor Fluorometer System (Bio-Rad) using Hoechst 33258 (Fluorescent DNA Quantitation Kit, Bio-Rad) according to the manufacturer's instructions. Equal amounts of DNA were used for each lane in the assays.
To prepare total RNA, U. maydis cultures were grown to an O.D.600 of 0.6. Sporidia were washed with PBS, centrifuged, and suspended in 3 ml of 20 mM sodium acetate buffer (pH 5.5); we then proceeded as previously described [51], [52]. After the final precipitation step, RNA was treated with RNase-free DNase, extracted twice with phenol-chloroform, and precipitated. The RNA was quantified by measuring the UV absorbance at 260 nm and assessed by PCR to detect any contaminating DNA.
Samples of RNA were treated with RNase-free recombinant DNase I (Roche, Mannheim, Germany) to remove contaminating DNA following the manufacturer's recommendations. Reverse transcription was performed using RevertAid H minus Reverse Transcriptase (PureExtreme, Fermentas, USA) and 1 µg DNA-free RNA, according to the manufacturer's instructions. Five microliters of synthesized cDNA was used as a template for PCR amplification with the CGFMD05 (5′ GTCTTTCCGCATTACGTCTACAGG 3′) and FATCR08 (5′ TCGCCTTTGCTGGAGCCTTTACG 3′) primers. Primers were designed based on the trt1 sequence, and they produced a 1222-bp product after amplifying DNA sequences spanning from gene positions 411 to 1633 nt. After a 5-min 94°C denaturation period, 25 amplification cycles were performed as follows: 70°C for 30 s, 72°C for 1 min 40 s, and 92°C for 50 s. PCR reactions were performed using Platinum Taq DNA Polymerase (Invitrogen) according to the manufacturer's instructions.
U. maydis transformation and one-step trt1 disruption
The transformation procedure was performed essentially as described [50], using protoplasts and polyethylene glycol 3350. The regeneration plates were prepared with MM or CM [48] supplemented with 1 M sorbitol and either 200 µg/ml hygromycin (Sigma-Aldrich) or 1 µg/ml carboxin (BioWorld) as selection agents. The transformed cells arose as hygromycin- or carboxin- resistant colonies after five days of incubation at 28°C. To analyze the senescence phenotype of the hygromycin-resistant transformants, single colonies from the transformation plates were streaked on agar or grown for up to 36 doubling periods in Holliday's MM under hygromycin (200 µg/ml) selection. The cultures were used for DNA extraction, and aliquots were stored in glycerol at −70°C.
For the one-step disruption of the putative trt1 gene, a ∼4,230-bp linear EcoRV fragment was obtained from the pCM1007 plasmid, which contains a disruption cassette. The cassette was an assembly of the bacterial hygromycin phosphotransferase gene (hph) expressed under the control of the Phsp70 U. maydis promoter. This marker gene was linked to two flanking fragments of the trt1 gene, an 847-bp fragment (from -11 to 836 nt) and a 1,334-bp fragment (from 2,777 to 4,111 nt), as suitable sequences for homologous recombination. The oligonucleotide primer pairs used to amplify these trt1 DNA fragments were EST2Afor (5′ GAAGAACTGAGATGCAGCC 3′) with EST2Arev (5′ CTGATTCGAGAAGTGACTCG 3′) for the 847-bp DNA fragment and EST2Bfor (5′ CGAGATCATCTTCGGCTTGC 3′) with EST2Brev (5′ TTGACAAGGACTTCTGAGCG 3′) for the 1,334-bp DNA fragment. Multiplex PCR amplification with three oligonucleotide primers (EST2 FDD1, EST2 RDD1, and HyRDD, provided by W.K. Holloman) distinguished between the wild-type and disrupted transformants. The EST2 FDD1 (5′ GGTACTTGCTTTGTGCAGC 3′) and EST2 RDD1 (5′ CTAACGACTCGACTTCAGC 3′) primer pair amplified a 904-bp trt1 fragment spanning from positions 595 to 1,498 nt. Additionally, the primer combination of HyRDD1 (5′ TCAGGCTCTCGCTGAATTCC 3′) and EST2 FDD1 amplified a fragment of approximately 1,286 bp that spanned part of the trt1 gene and part of the hph gene. A third primer pair of HyRDD1 and EST2FDD2 (5′ TTGCGCAACTTCCTACGAGACT 3′, positioned from −62 nt to −40 of trt1) amplified a 1,942-bp DNA fragment that confirmed the trt1 disruption in the mutants. Two independent clones derived from the U. maydis 521 strain (trt1-1 and trt1-2) were obtained and used for subsequent analysis; one independent clone derived from the 520 strain (520trt1-1) was also used in this study (Table 3).
Cloning trt1 under control of the HSP70 promoter
The forward primer ExTelF00 (5′ ATGCAGCCACCCAAATCCAG 3′) and the reverse primer ExTelRv1 (5′ GCAGCTGGCACGTTGACACA 3′) were used to amplify entire ORF of the trt1 gene (positions 1 to 4,116 plus 58 bp of the downstream sequence). Thirty PCR cycles were performed with Platinum Taq DNA Polymerase (Invitrogen) according to the manufacturer's instructions. In each cycle, the sample was denatured at 94°C for 30 s, annealed at 61°C for 30 s, and extended at 72°C for 5 min. The pTrt1 vector is a pNEBUC GE77+ derivative that contains trt1 under the control of PHSP70 and THSP70. This vector was constructed as detailed below. An amplified 4,171-bp fragment spanning the entire trt1 ORF was inserted into the EcoRV site in pBluescript KS-. The resulting plasmid, pTelMI, was linearized with BamHI and partially digested with XhoI to retrieve trt1, which was then inserted into the pTrcHis 2A (Invitrogen) plasmid to obtain the pTelMII plasmid. A 2.1-kb HindIII fragment from the pUBLEX1 vector carrying the PHSP70 promoter and THSP70 terminator sequences separated by a BglII site was subcloned into the pBluescript KS- vector (Stratagene) to obtain pSVM1. A 4.2-kb BamHI/BglII (partial digestion) fragment from the pTelMII plasmid carrying the trt1 sequences was inserted into the BglII site of pSVM1 in the proper orientation to obtain pTelM70. The BamHI/KpnI fragment encoding Trt1 under the control of the HSP70 promoter and terminator was subcloned into the replicative pNEBUC GE77+ vector to obtain pTrt1.
After transforming U. maydis strains with the plasmid, total DNA was isolated from transformant clones, and the oligonucleotide pair CGFMD05 and HSPseqD (5 GCGTCTGTGCGGCGATGAG 3′, located at position 605 to 623 nt of the 786-bp HSP70 promoter) was used to detect the chimeric gene by amplifying a 1813-bp DNA fragment spanning part of the PHSP70 promoter and part of the trt1 ORF gene.
The TRF analysis in U. maydis
This analysis was conducted as previously described by Sanchez-Alonso et al. [31]. DNA samples were digested to completion with PstI (Invitrogen). DNA fragment size fractionation was performed via electrophoresis on a 1.0% agarose gel, and the resolved products were transferred to a nylon membrane (Hybond-N, Invitrogen) as described elsewhere [51]. Hybridization was performed at 65°C in Church's buffer at a probe activity of 17 kBq/ml [53]. One of the probes used in this study was UT1-a, which spans 240 bp of the telomeric repeat sequence (TTAGGG)39 plus 329 bp from a highly conserved subtelomeric sequence composed of the TR-p + TR-d fragments [31]. UT1-a was digested to completion with HincII (Invitrogen) to separate the telomere repeat sequence (TTAGGG)n from the adjacent subtelomeric sequences to use as individual probes. The UT4-a probe, which is derived from the subtelomeric UTASa (Accession AF030885.1), was also used in the hybridization assays [32]. Probes were labeled using the Random Primers DNA Labeling System (Invitrogen) and used as previously described [32]. Washes were conducted at 25°C and included two washes with 5× SSPE and 0.2% SDS and one wash with 2× SSPE and 0.1% SDS, with gentle shaking for 15 s. When necessary, additional washes with 2× SSPE or 0.4× SSPE plus 0.1% SDS were performed. To reuse the membranes, the probes were removed by gently shaking the membrane in a boiling solution of 0.1% SDS and 0.1× SSPE for 1 min. The solution was then discarded, and this treatment was repeated at least twice (20× SSPE: 3 M NaCl, 0.2 M NaH2PO4•H2O, 0.02 M EDTA, and pH = 7.4).
The telomeric repeat amplification protocol (TRAP) in U. maydis
To measure the telomerase activity we used the TRAP, which has been described previously by Kim et al. [54]. To obtain protein extracts from different strains, 1000- ml cultures were grown to a D.O.600 of 0.6. Cells were harvested by centrifugation, washed once in PBS, and resuspended at approximately 109 cells/ml in lysis buffer containing the following: 10 mM Tris-HCl (pH 7.5), 1 mM MgCl2, 10% glycerol, 1 mM EGTA (Sigma-Aldrich, St. Louis, MO, USA), 0.5% Tween 20, and 1 mM dithiothreitol (Amersham Biosciences, Piscataway, NJ, USA). The protease inhibitor cocktail described by Masutomi et al. [55] was used, with slight modifications as follows: the inhibitors were used at one-tenth the prescribed concentration, the benzamidine HCl concentration was increased to 160 µg/ml (0.1 mM), the phenanthrorin was replaced with 5 µg/ml chymostatin (Sigma), and 50 U/ml of the RNase inhibitor SUPERase•In (Ambion, Austin, TX, USA) was added. The mixture was frozen in liquid nitrogen, ground to a powder, mixed with 200 µl of cold lysis buffer, and incubated on ice for 30 min. The lysates were centrifuged for 45 min at 25,000×g at 4°C, and the supernatant was divided into aliquots, frozen in liquid nitrogen, and stored at −70°C until use. Galls (from 12-day-old plants) and maize leaves or meristems (from 20-day-old plants) were frozen in liquid nitrogen or ground to powder following the same protocol. To determine telomerase activity, the sample protein concentrations were adjusted to 0.1 µg/µl with lysis buffer, and 0.1 µg of the protein extract was poured into a tube containing elongation buffer [56], which was modified with 30 mM Tris-HCl (pH 8.3) and 0.25 mg BSA. The reaction mixture was brought to a final volume of 20 µl and incubated for 30 min at 30°C. To amplify the elongated G-rich strand of telomere repeats, 10 µl of the prior mixture was used for PCR using FastStart Taq DNA polymerase (Roche), according to the manufacturer's instructions. The mixture was subjected to 30 cycles of 95°C for 30 s, 50°C for 30 s, and 72°C for 1 min using a TS primer (5′ AATCCGTCGAGCAGAGTT 3′) plus a CX (5′ CCCTAACCCTAACCCTAACCCTAA 3′) reverse primer. The supplied HEK293 cell line extracts were heat-inactivated at 85°C for 15 min and used as negative controls. Heat-inactivated extracts of U. maydis strains or RNase-treated samples were also used as telomerase-negative fungal controls. The TeloTAGGG Telomerase PCR ELISA kit (Roche) was used to determine telomerase activity accordingly to manufacturer's instructions. The average absorbance value (A) for each sample was calculated as recommended, A = A450 (reading) - A690 (blank). To calculate the difference in absorbance (ΔA), we subtracted the mean of the absorbance of the negative controls from the mean sample absorbance. The samples were identified as telomerase positive if the difference in absorbance (ΔA = Asample - A neg. control) was higher than 0.2 units. Further details of the manufacturer's protocol can be found in the TeloTAGGG Telomerase PCR ELISA manual (V8.0 p.15). Statistical analyses were conducted using the Mann-Whitney test, which was designed to compare differences between two independent groups [57]. The GraphPad Prism V.6.0b program (GraphPad Software, La Jolla, CA, USA) was used following the manufacturer's instructions (www.graphpad.com/guides/prism/5/user-guide/prism5help.html?stat_how_to_do_an_unpaired_t_test_w_3.html). Figures 4 and S1D were created with GraphPad Prism V.6.0b using results of the Kruskal-Wallis test (one-way ANOVA data test), which is an extension of the Mann-Whitney U test used to compare two or more samples.
Exonuclease digestion of U. maydis DNA
The assay was performed with Bal31 exonuclease (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. Briefly, 1 µg of total DNA was adjusted to 250 µl with the 1× Bal31 nuclease buffer provided by the manufacturer. Samples (62 µl) were removed at regular intervals depending on the strain. The reactions were terminated by adding EGTA (Sigma) to a final concentration of 10 mM. The samples were ethanol precipitated, and the DNA was digested with PstI (Invitrogen) and electrophoresed on 1% agarose gels. The samples were then transferred to nylon membranes (GeneScreen Plus, Hybridization Transfer Membrane, Perkin Elmer Inc., Alameda, CA, USA) and hybridized to (TTAGGG)n, UT4-a, both, or rRNA gene sequences as a probe.
Supporting Information
Acknowledgments
We thank Dr. W.K. Holloman for his kind contributions to this work with strains, oligonucleotide primers and his valuable help in commenting the results and editing the manuscript. We also thank Dr. Peter Schreier for his help with the initial sequence analysis as well as the international Ustilago maydis community for their kind comments throughout the development of this work. We are also grateful to Moises Carcaño Montiel, who provided the MCS-02 maize line used in this study. Furthermore, we thank Arturo Ortiz Tepox and the students from the Centro de Bachillerato Tecnologico Industrial y de Servicios for their helpful assistance.
Funding Statement
This work was supported by CONACyT 46378-Q and CONACyT CB106140-P2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Cairney CJ, Keith WN (2008) Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie 90: 13–23. [DOI] [PubMed] [Google Scholar]
- 2. Podlevsky JD, Chen JJ (2012) It all comes together at the ends: telomerase structure, function, and biogenesis. Mutation research 730: 3–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Martinez P, Blasco MA (2011) Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11: 161–176. [DOI] [PubMed] [Google Scholar]
- 4. Ding D, Zhou J, Wang M, Cong YS (2013) Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J 280: 3205–3211. [DOI] [PubMed] [Google Scholar]
- 5. Cukusic A, Skrobot Vidacek N, Sopta M, Rubelj I (2008) Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res 122: 263–272. [DOI] [PubMed] [Google Scholar]
- 6. Westin ER, Chavez E, Lee KM, Gourronc FA, Riley S, et al. (2007) Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts. Aging Cell 6: 383–394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Gomez DL, Farina HG, Gomez DE (2013) Telomerase regulation: a key to inhibition? (Review). Int J Oncol 43: 1351–1356. [DOI] [PubMed] [Google Scholar]
- 8. Cifuentes-Rojas C, Shippen DE (2012) Telomerase regulation. Mutation research 730: 20–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Redon S, Zemp I, Lingner J (2013) A three-state model for the regulation of telomerase by TERRA and hnRNPA1. Nucleic Acids Res 41: 9117–9128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Flores I, Benetti R, Blasco MA (2006) Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 18: 254–260. [DOI] [PubMed] [Google Scholar]
- 11. Armstrong L, Lako M, Lincoln J, Cairns PM, Hole N (2000) mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech Dev 97: 109–116. [DOI] [PubMed] [Google Scholar]
- 12. Ding Z, Wu CJ, Jaskelioff M, Ivanova E, Kost-Alimova M, et al. (2012) Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 148: 896–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Choudhary B, Karande AA, Raghavan SC (2012) Telomere and telomerase in stem cells: relevance in ageing and disease. Frontiers in bioscience 4: 16–30. [DOI] [PubMed] [Google Scholar]
- 14. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458–460. [DOI] [PubMed] [Google Scholar]
- 15. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V (1996) Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144: 1399–1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Teng SC, Zakian VA (1999) Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae . Mol Cell Biol 19: 8083–8093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hu Y, Tang HB, Liu NN, Tong XJ, Dang W, et al. (2013) Telomerase-null survivor screening identifies novel telomere recombination regulators. PLoS Genet 9: e1003208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Longo VD, Shadel GS, Kaeberlein M, Kennedy B (2012) Replicative and chronological aging in Saccharomyces cerevisiae . Cell metabolism 16: 18–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Christensen JJ (1963) Corn smut caused by Ustilago maydis. In: Soc AP, editor. American Phytopathology Society Monograph, No 2. St. Paul, MN: Am. Phythopathol. Soc. pp. 1–41. [Google Scholar]
- 20. Holliday R (2004) Early studies on recombination and DNA repair in Ustilago maydis . DNA Repair (Amst) 3: 671–682. [DOI] [PubMed] [Google Scholar]
- 21. Holloman WK, Schirawski J, Holliday R (2008) The homologous recombination system of Ustilago maydis . Fungal Genet Biol 45 Suppl 1: S31–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Dean R, Van Kan JA, Pretorius ZA, Hammond-Kosack KE, Di Pietro A, et al. (2012) The Top 10 fungal pathogens in molecular plant pathology. Molecular plant pathology 13: 414–430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Banuett F, Herskowitz I (1989) Different a alleles of Ustilago maydis are necessary for maintenance of filamentous growth but not for meiosis. Proc Natl Acad Sci U S A 86: 5878–5882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Spellig T, Bolker M, Lottspeich F, Frank RW, Kahmann R (1994) Pheromones trigger filamentous growth in Ustilago maydis . EMBO J 13: 1620–1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Gillissen B, Bergemann J, Sandmann C, Schroeer B, Bolker M, et al. (1992) A two-component regulatory system for self/non-self recognition in Ustilago maydis . Cell 68: 647–657. [DOI] [PubMed] [Google Scholar]
- 26. Kamper J, Reichmann M, Romeis T, Bolker M, Kahmann R (1995) Multiallelic recognition: nonself-dependent dimerization of the bE and bW homeodomain proteins in Ustilago maydis . Cell 81: 73–83. [DOI] [PubMed] [Google Scholar]
- 27. Brefort T, Doehlemann G, Mendoza-Mendoza A, Reissmann S, Djamei A, et al. (2009) Ustilago maydis as a Pathogen. Annu Rev Phytopathol 47: 423–445. [DOI] [PubMed] [Google Scholar]
- 28. Vollmeister E, Schipper K, Baumann S, Haag C, Pohlmann T, et al. (2012) Fungal development of the plant pathogen Ustilago maydis . FEMS microbiology reviews 36: 59–77. [DOI] [PubMed] [Google Scholar]
- 29. Schirawski J, Mannhaupt G, Munch K, Brefort T, Schipper K, et al. (2010) Pathogenicity determinants in smut fungi revealed by genome comparison. Science 330: 1546–1548. [DOI] [PubMed] [Google Scholar]
- 30. Guzman PA, Sanchez JG (1994) Characterization of telomeric regions from Ustilago maydis . Microbiology 140 (Pt 3): 551–557. [DOI] [PubMed] [Google Scholar]
- 31. Sanchez-Alonso P, Valverde ME, Paredes-Lopez O, Guzman P (1996) Detection of genetic variation in Ustilago maydis strains by probes derived from telomeric sequences. Microbiology 142 (Pt 10): 2931–2936. [DOI] [PubMed] [Google Scholar]
- 32. Sanchez-Alonso P, Guzman P (1998) Organization of chromosome ends in Ustilago maydis. RecQ-like helicase motifs at telomeric regions. Genetics 148: 1043–1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Kelleher C, Teixeira MT, Forstemann K, Lingner J (2002) Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci 27: 572–579. [DOI] [PubMed] [Google Scholar]
- 34. Zvereva MI, Shcherbakova DM, Dontsova OA (2010) Telomerase: structure, functions, and activity regulation. Biochemistry Biokhimiia 75: 1563–1583. [DOI] [PubMed] [Google Scholar]
- 35. Lundblad V, Blackburn EH (1993) An alternative pathway for yeast telomere maintenance rescues est1− senescence. Cell 73: 347–360. [DOI] [PubMed] [Google Scholar]
- 36. Huang P, Pryde FE, Lester D, Maddison RL, Borts RH, et al. (2001) SGS1 is required for telomere elongation in the absence of telomerase. Curr Biol 11: 125–129. [DOI] [PubMed] [Google Scholar]
- 37. Makovets S, Williams TL, Blackburn EH (2008) The telotype defines the telomere state in Saccharomyces cerevisiae and is inherited as a dominant non-Mendelian characteristic in cells lacking telomerase. Genetics 178: 245–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, et al. (2010) Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A 107: 10148–10153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Yang C, Przyborski S, Cooke MJ, Zhang X, Stewart R, et al. (2008) A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 26: 850–863. [DOI] [PubMed] [Google Scholar]
- 40. Kalmbach KH, Fontes Antunes DM, Dracxler RC, Knier TW, Seth-Smith ML, et al. (2013) Telomeres and human reproduction. Fertil Steril 99: 23–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Walbot V, Skibbe DS (2010) Maize host requirements for Ustilago maydis tumor induction. Sexual plant reproduction 23: 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, et al. (2005) The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A 102: 17119–17124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Mozdy AD, Cech TR (2006) Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. RNA 12: 1721–1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Chen XF, Meng FL, Zhou JQ (2009) Telomere recombination accelerates cellular aging in Saccharomyces cerevisiae . PLoS genetics 5: e1000535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Yu EY, Kojic M, Holloman WK, Lue NF (2013) Brh2 and Rad51 promote telomere maintenance in Ustilago maydis, a new model system of DNA repair proteins at telomeres. DNA Repair (Amst) 12: 472–479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Gold SE, Bakkeren G, Davies JE, Kronstad JW (1994) Three selectable markers for transformation of Ustilago maydis . Gene 142: 225–230. [DOI] [PubMed] [Google Scholar]
- 47. Brachmann A, Konig J, Julius C, Feldbrugge M (2004) A reverse genetic approach for generating gene replacement mutants in Ustilago maydis . Mol Genet Genomics 272: 216–226. [DOI] [PubMed] [Google Scholar]
- 48.Holliday R (1974) Ustilago maydis. In: King RC, editor. Handbook of genetics. London: Plenum Press. pp. 575–595. [Google Scholar]
- 49. Puhalla JE (1968) Compatibility reactions on solid medium and interstrain inhibition in Ustilago maydis . Genetics 60: 461–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Tsukuda T, Carleton S, Fotheringham S, Holloman WK (1988) Isolation and characterization of an autonomously replicating sequence from Ustilago maydis . Mol Cell Biol 8: 3703–3709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning. A laboratory manual. Cold Spring Harbor: Cold Sring Harbor Laboratory Press. [Google Scholar]
- 52. Vazquez-Cruz C, Olmedo-Alvarez G (1997) Mechanism of decay of the cry1Aa mRNA in Bacillus subtilis . J Bacteriol 179: 6341–6348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci U S A 81: 1991–1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015. [DOI] [PubMed] [Google Scholar]
- 55. Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, et al. (2000) Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. The Journal of biological chemistry 275: 22568–22573. [DOI] [PubMed] [Google Scholar]
- 56. Dalla Torre CA, Maciel RM, Pinheiro NA, Andrade JA, De Toledo SR, et al. (2002) TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines. Braz J Med Biol Res 35: 65–68. [DOI] [PubMed] [Google Scholar]
- 57. Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 8: 50–60. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.